New study to test antifungal drug safety in organ transplant patients
NCT ID NCT07656493
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will observe 120 solid organ transplant recipients who have invasive fungal infections. Researchers will track how well the drug liposomal amphotericin B works and its side effects, compared to historical patients who received other antifungal treatments. The goal is to gather real-world evidence to guide better dosing and monitoring in this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Liposomal amphotericin B (an antifungal drug)
- What this could lead to
- If successful, this study could provide real-world data to help doctors better treat fungal infections in transplant patients, potentially improving survival and reducing side effects.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. It is also small (120 participants) and single-center, limiting how widely findings can be applied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a wearable glucose sensor be trusted in the ICU? new study aims to find out
- 5,000 patients to help unlock secrets of kidney disease and transplant outcomes
- Can hospitals boost vaccine access for the most vulnerable?
- New study aims to unlock secrets of CMV in transplant patients
- Study investigates hidden health risks for children of transplant mothers
- Oxygen chamber therapy put to the test for dozens of diseases